NMPA Approval

Mesalazine Gastro-resistant Prolonged-release Granules

Approval Number

国药准字H20244970

Company江苏安必生制药有限公司

Registration Date

September 26, 2024

Drug Information

Generic Name

美沙拉秦肠溶缓释颗粒

Dosage Form

颗粒剂

Strength

0.5g

Drug Type

化学药品

Registration Date

September 26, 2024

Company Information

Applicant Company

Company Name江苏安必生制药有限公司

Company Address

泰州市医药高新技术产业开发区医药高新技术产业园第五期标准厂房G110栋

Manufacturing Company

Company Name江苏安必生制药有限公司

Company Address

泰州市医药高新技术产业开发区医药高新技术产业园第五期标准厂房G110栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

美沙拉秦肠溶缓释颗粒 - NMPA 批准文号 | MedPath